Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Leukemia-Lymphoma, Adult T-Cell 1Leukemia, T-Cell 1HTLV-I Infections 1Diabetes Mellitus, Insulin-Dependent, 10 1

Interventions

pegaspargase 2Vincristine 2Methotrexate 2Cytarabine 2ruxolitinib 1palbociclib 1nelarabine 1Prednisone 1Prednisolone 1Panobinostat 1Mitoxantrone 1Mercaptopurine 1Hydrocortisone 1Etoposide 1Doxorubicin 1Dexamethasone 1Daclizumab 1Cyclophosphamide 1Clofarabine 1Calcium Dobesilate 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Leukemia, T-Cell × Daclizumab × Clear all
NCT00001941 2012-08-20

Anti-Tac for Treatment of Leukemia

National Institutes of Health Clinical Center (CC)

Phase 1/2 Completed
34 enrolled 12 charts
LymphoidOther hematologic neoplasm

Diabetes Mellitus, Insulin-Dependent, 10, Leukemia, T-Cell, Leukemia-Lymphoma, Adult T-Cell, HTLV-I Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡